Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 2—February 2020
Research

Unique Clindamycin-Resistant Clostridioides difficile Strain Related to Fluoroquinolone-Resistant Epidemic BI/RT027 Strain

Andrew M. SkinnerComments to Author , Laurica Petrella, Farida Siddiqui, Susan P. Sambol, Christopher A. Gulvik, Dale N. Gerding, Curtis J. Donskey, and Stuart JohnsonComments to Author 
Author affiliations: Edward Hines, Jr. VA Hospital, Hines, Illinois, USA (A.M. Skinner, L. Petrella, F. Siddiqui, D.N. Gerding, S. Johnson); Loyola University Medical Center, Maywood, Illinois, USA (A.M. Skinner, S. Johnson); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.A. Gulvik); Louis Stokes VA Hospital, Cleveland, Ohio, USA (C.J. Donskey); Case Western Reserve University, Cleveland (C.J. Donskey)

Main Article

Table

Comparison of baseline characteristics and outcomes of patients colonized or infected with Clostridioides difficile DQ/591, BI/NAP1/027, and other strain types in study of C. difficile at 2 US Veteran Affairs long-term care facilities and their affiliated acute care facilities*

Characteristic Strain type
DQ/591, n = 15 BI/027, n = 22 Other, n = 27
Age, y (range)
67.9 (49–85)
68.9 (57–89)
67.4 (48–91)
Sex
M 15 (100) 22 (100) 26 (96)
F
0
0
1 (4)
Residence
Long-term care facility 10 (67) 7 (32)† 8 (30)†
Spinal cord injury unit
4 (27)
8 (36)
7 (26)
Drugs received
Proton pump inhibitor 12 (80) 11 (50) 19 (70)
Antimicrobial drug treatment in past 90 d 15 (100) 14 (64)† 15 (56)†
Fluoroquinolone in past 90 d 5 (33) 6 (27) 6 (22)
Clindamycin in past 90 d 1 (7) 0 0
Azithromycin in past 90 d
1 (7)
0
0
Intensive care unit admission in past 30 d
4 (27)
4 (18)
0†
Medical conditions
Chronic lung disease 6 (40) 4 (18) 5 (19)
Cancer 5 (33) 5 (23) 5 (19)
Major surgery in past 90 d 3 (20) 1 (4.5) 5 (19)
End-stage renal disease
3 (20)
4 (18)
4 (15)
Disease classification, no. (%)
C. difficile infection 7 (47) 13 (59) 16 (59)
Severe 3 (43) 3 (23) 1 (6)
Fulminant 0 0 0
Recurrent 3 (43) 2 (15) 4 (25)
Healthcare-associated 7 (100) 11 (85) 8 (50)†
Asymptomatic carrier 8 (53) 9 (41) 11 (41)
Died within 6 mo after CDI diagnosis 4 (27) 6 (27) 1 (4)†

*Values for BI/027 and for other strain types were compared with values for DQ/591 strains.
†p<0.05.

Main Article

Page created: January 17, 2020
Page updated: January 17, 2020
Page reviewed: January 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external